Population-based study of acute- and long-term care costs after stroke in patients with AF

International Journal of Stroke

Volumn 8, Issue 5, 2013, Pages 308-314

  Luengo Fernandez, Ramon ^a   Yiin, Gabriel S C ^a   Gray, Alastair M ^a   Rothwell, Peter M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Atrial fibrillation; Cost factors; Economics; Institutionalization; Resource use; Stroke

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; EMERGENCY CARE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HUMAN; INSTITUTIONALIZATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NURSING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESIDENTIAL CARE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COMMUNITY HEALTH PLANNING; FEMALE; HEALTH CARE COSTS; HUMANS; LONG-TERM CARE; LONGITUDINAL STUDIES; MALE; STROKE; TIME FACTORS;

EID: 84879486101     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00812.x     Document Type: Article

References (29)

1. Luengo-Fernandez R, Leal J, Gray A, Petersen S, Rayner M. Cost of cardiovascular diseases in the United Kingdom. Heart 2006; 92 : 1384-1389.
2. Feigin VL, Lawes CMM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003; 2 : 43-53.
3. Sturm J, Dewey HM, Donnan GA, Macdonell RAL, McNeil JJ, Thrift AG. Handicap after stroke: how does it relate to disability, perception of recovery, and stroke subtype? The North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2002; 33 : 762-768.
4. Lin HJ, Wolf PA, Kelly-Hayes M etal. Stroke severity in AF: the Framingham study. Stroke 1996; 27 : 1760-1764.
5. Diringer MN, Edwards DF, Mattson DT etal. Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke 1999; 30 : 724-728.
6. Luengo-Fernandez R, Gray A, Rothwell PM. Population-based study of determinants of initial secondary care costs of acute stroke in the United Kingdom. Stroke 2006; 37 : 2579-2587.
7. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25 : 457-507.
8. Furie KL, Kasner SE, Adams RJ etal. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42 : 227-276.
9. Connolly SJ, Eikelboom J, Joyner C etal. Apixaban in patients with atrial fibrillation. N Engl J Med 2011; 364 : 806-817.
10. Connolly SJ, Ezekowitz MD, Yusuf S etal. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361 : 1139-1151.
11. Freeman JV, Zhu RP, Owens DK etal. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med 2011; 154 : 1-11.
12. Sculpher MJ, Claxton K, Drummond MF, McCabe C. Whither trial-based economic evaluation for health care decision making? Health Econ 2006; 15 : 677-687.
13. Luengo-Fernandez R, Gray AM, Rothwell PM. Costs of stroke using patient-level data: a critical review of the literature. Stroke 2009; 40 : e18-23.
14. Feigin VL, Van der Hoorn S. How to study stroke incidence. Lancet 2004; 363 : 1920.
15. Rothwell PM, Coull AJ, Silver LE etal. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366 : 1773-1783.
16. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. Eur Heart J 2010; 31 : 2369-2429.
17. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19 : 604-607.
18. Curtis L. Unit Costs of Health and Social Care 2009. Canterbury, Kent, Personal Social Services Research Unit, 2009.
19. National Health Service. NHS reference costs 2008-2009. Department of Health; 2010. Available at http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_111591 (accessed 26 June 2010).
20. National Health Service. Annual Financial Returns of NHS Trusts, 2003-2004. Leeds, NHS Executive, 2005.
21. Patel A, Knapp M, Perez I, Evans A, Kalra L. Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial. Stroke 2004; 35 : 196-204.
22. Rothwell PM, Giles MF, Chandratheva A etal. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007; 370 : 1432-1442.
23. Ricci J-F, Martin BC. Resource utilizations of ischemic stroke patients: a population study of Georgia Medicaid recipients. J Res Pharm Econ 1998; 9 : 21-34.
24. Leibson CL, Hu T, Brown RD, Hass SL, O'Fallon WM. Utilization of acute care services in the year before and after first stroke: a population-based study. Neurology 1996; 46 : 861-869.
25. Kirkwood BR, Sterne JAC. Essential Medical Statistics, 2nd edn. Oxford, Blackwell Science, 2003.
26. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ etal. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12 : 1360-1420.
27. Feigin VL, Carter K, Hackett M etal. Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002-2003. Lancet Neurol 2006; 5 : 130-139.
28. Cabral NL, Goncalves ARR, Longo AL etal. Incidence of stroke subtypes, prognosis and prevalence of risk factors in Joinville, Brazil: a 2 year community based study. J Neurol Neurosurg Psychiatry 2009; 80 : 755-761.
29. Hannon N, Callaly E, Moore A etal. Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study. Stroke 2011; 42 : 2503-2508.